Corticosteroids and cardiopulmonary bypass: A review of clinical investigations

Chest

Volumn 121, Issue 3 SUPPL., 2002, Pages 921-931

  Chaney, Mark A ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cardiopulmonary bypass; Corticosteroids; Systemic inflammatory response syndrome

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE; PLACEBO;

CARDIOPULMONARY BYPASS; CLINICAL TRIAL; DRUG EFFECT; HEART SURGERY; HUMAN; INFLAMMATION; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 0036203002     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.121.3.921     Document Type: Review

References (66)

1. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass
2. The systemic inflammatory response
3. Methyl-prednisolone does not benefit patients undergoing coronary artery bypass grafting and early tracheal extubation
4. Association of fast-track cardiac management and low-dose to moderate-dose glucocorticoid administration with perioperative hyperglycemia
5. Hemodynamic effects of methylprednisolone in patients undergoing cardiac operation and early extubation
6. Does steroid pretreatment increase endotoxin release during clinical cardiopulmonary bypass?
7. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?
8. Methylprednisolone reduces the inflammatory response to cardiopulmonary bypass in neonatal piglets: Timing of dose is important
9. Influence of methylprednisolone on cytokine balance during cardiac surgery
10. Pulmonary effects of methylprednisolone in patients undergoing coronary artery bypass grafting and early tracheal extubation
11. Modifying risk for extracorporeal circulation: Trial of four anti-inflammatory strategies
12. Methylprednisolone and full-dose aprotinin reduce reperfusion injury after cardiopulmonary bypass
13. Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass
14. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients
15. Effect of methylprednisolone on complement activation during heparin neutralization
16. Effect of methylprednisolone on the oxidative burst activity, adhesion molecules and clinical outcome following open heart surgery
17. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men
18. Steroid administration in heart and heart-lung transplantation: Is the timing adequate?
19. Influence of steroids on complement and cytokine generation after cardiopulmonary bypass
20. Glucocorticoid reduction of bronchial epithelial inflammation during cardiopulmonary bypass
21. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery
22. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans
23. Methylprednisolone inhibits increase of interleukin 8 and 6 during open heart surgery
24. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans
25. Interleukin-8 production in patients undergoing cardiopulmonary bypass: The influence of pretreatment with methylprednisolone
26. Methylprednisolone does not influence endotoxin translocation during cardiopulmonary bypass
27. The role of different types of corticosteroids on the inflammatory mediators in cardiopulmonary bypass
28. Effect of methylprednisolone on endotoxemia and complement activation during cardiac surgery
29. Effects of methylprednisolone on complement activation and lukocyte counts during cardiopulmonary bypass
30. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass
31. Complement activation during cardiopulmonary bypass: Comparison of bubble and membrane oxygenators
32. The effect of methylprednisolone on complement activation during cardiopulmonary bypass
33. Complement activation during cardiopulmonary bypass: Quantitative study of effects of methylprednisolone and pulsatile flow
34. Plasma levels of methylprednisolone following administration during cardiac surgery
35. Complement activation and neutropenia occurring during cardiopulmonary bypass
36. Methylprednisolone prior to cardiopulmonary bypass
37. Steroids in heart surgery: A clinical double-blind and randomized study
38. Complement activation during cardiopulmonary bypass
39. Effects of glucocorticosteroids in patients undergoing coronary artery bypass surgery
40. Methylprednisolone and lung function after cardiopulmonary bypass
41. Beneficial effects of methylprednisolone in patients on cardiopulmonary bypass
42. Lysosomal enzyme release from the lungs after cardiopulmonary bypass
43. The effects of methylprednisolone on the complications of coronary artery surgery
44. Effect of methylprednisolone on myocardial preservation during coronary artery surgery
45. The use of methylprednisolone during cardiopulmonary bypass: A review of 427 cases
46. Ineffectiveness of methylprednisolone in the treatment of pulmonary dysfunction after cardiopulmonary bypass
47. Pulmonary cellular changes prevented or altered by methyl prednisolone sodium succinate
48. Corticosteroids as effective vasodilators in the treatment of low output syndrome
49. Adrenocorticotropic hormone, adrenocortical steroids and their synthetic analogs: Inhibitors of adrenocortical steroid biosynthesis
50. Corticosteroids for reversal of hemorrhagic shock in rats
51. Acute pharmacodynamic effects of glucocorticoids; cardiac output and related hemodynamic changes in normal subjects and patients in shock
52. Effect of corticosteroid on the acidosis of prolonged cardiopulmonary bypass
53. Use of corticosteroids during cardiopulmonary bypass: Possible lysosome stabilization
54. Effects of corticosteroids on the circulation in shock: Experimental and clinical results
55. Effects of a single large intravenous dose of methylprednisolone sodium succinate
56. Effect of methylprednisolone on predicted myocardial infarction size in man
57. Protective effect of methylprednisolone on the heart during ischemic arrest
58. Protective action of methylprednisolone on the myocardium during experimental myocardial ischemia in the cat
59. Reduction of experimental myocardial infarct size by corticosteroid administration
60. Complement and the damaging effects of cardiopulmonary bypass
61. Complement activation during cardiopulmonary bypass; evidence for generation of C3a and C5a anaphylatoxins
62. Aprotinin and the systemic inflammatory response after cardiopulmonary bypass
63. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass
64. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation
65. Humoral immune response during coronary artery bypass grafting; a comparison of limited approach, "off-pump" technique, and conventional cardiopulmonary bypass
66. Myocardial outflow of prostacyclin in relation to metabolic stress during off-pump coronary artery bypass grafting